Clinical Trials Directory

Trials / Completed

CompletedNCT02202811

Circadian Rhythms and Cardiovascular Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to understand how behaviors and the effects of the body's internal clock (called the circadian pacemaker) affect the control of the heart and blood pressure. People with Obstructive Sleep Apnea (OSA) are hypothesized to have altered circadian amplitudes in certain key indices of cardiovascular (CV) and an abnormally advanced circadian phase in some of the same key indices of CV risk. The investigators hypothesize that such changes, taken together, may explain the different timing of heart attack and sudden cardiac death in OSA.

Conditions

Interventions

TypeNameDescription
BEHAVIORALForced Desynchronyall sleep opportunities and other activities will be scheduled by the experimenter so that by the end of the study these activities are spread evenly across all phases of the internal body clock.

Timeline

Start date
2014-08-01
Primary completion
2020-03-09
Completion
2020-03-09
First posted
2014-07-29
Last updated
2025-07-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02202811. Inclusion in this directory is not an endorsement.

Circadian Rhythms and Cardiovascular Risk (NCT02202811) · Clinical Trials Directory